Equities

Q linea AB

Q linea AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)1.11
  • Today's Change0.01 / 0.91%
  • Shares traded101.15k
  • 1 Year change-63.25%
  • Beta1.1137
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments8273166
Total Receivables, Net2.984652
Total Inventory474229
Prepaid expenses362.471.93
Other current assets, total------
Total current assets167163248
Property, plant & equipment, net565847
Goodwill, net4.894.894.89
Intangibles, net0.130.240.39
Long term investments4.103.00184
Note receivable - long term0.050.050.05
Other long term assets----0.00
Total assets232230484
LIABILITIES
Accounts payable5.31228.10
Accrued expenses9.671314
Notes payable/short-term debt000.08
Current portion long-term debt/capital leases7.666.124.93
Other current liabilities, total6.811213
Total current liabilities295241
Total long term debt131513
Total debt212118
Deferred income tax------
Minority interest------
Other liabilities, total--0.00--
Total liabilities426754
SHAREHOLDERS EQUITY
Common stock5.861.481.48
Additional paid-in capital1,4831,2351,235
Retained earnings (accumulated deficit)(1300)(1073)(806)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.00--0.00
Total equity190163430
Total liabilities & shareholders' equity232230484
Total common shares outstanding1173030
Treasury shares - common primary issue0.330.330.33
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.